BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Moodys
Argus Health
Dow
Queensland Health
Federal Trade Commission
Daiichi Sankyo
AstraZeneca
Chinese Patent Office
McKesson
Mallinckrodt

Generated: January 17, 2018

DrugPatentWatch Database Preview

Carboplatin - Generic Drug Details

« Back to Dashboard

What are the generic sources for carboplatin and what is the scope of carboplatin freedom to operate?

Carboplatin
is the generic ingredient in two branded drugs marketed by Cipla Ltd, Fresenius Kabi Usa, Hospira, Mylan Labs Ltd, Pliva, Sandoz, Watson Labs Teva, West-ward Pharms Int, Corden Pharma, Accord Hlthcare, Actavis Totowa, Akorn, Fresenius Kabi Oncol, Gland Pharma Ltd, Ingenus Pharms Llc, Mylan Institutional, Nanjing King-friend, Pharmachemie Bv, Pliva Lachema, Sandoz Inc, Sanja Pharms Co, Sun Pharma Global, Teva Parenteral, Teva Pharms Usa, and Cordenpharma, and is included in thirty-five NDAs. Additional information is available in the individual branded drug profile pages.

There are eighteen drug master file entries for carboplatin. Twelve suppliers are listed for this compound. There is one tentative approval for this compound.
Pharmacology for carboplatin
Medical Subject Heading (MeSH) Categories for carboplatin
Tentative approvals for CARBOPLATIN
Applicant Application No. Strength Dosage Form
➤ Subscribe➤ Subscribe50MG/VIALINJECTABLE;INJECTION
➤ Subscribe➤ Subscribe450MG/VIALINJECTABLE;INJECTION
➤ Subscribe➤ Subscribe150MG/VIALINJECTABLE;INJECTION

US Patents and Regulatory Information for carboplatin

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pharmachemie Bv CARBOPLATIN carboplatin INJECTABLE;IV (INFUSION) 077679-001 Feb 25, 2009 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Fresenius Kabi Usa CARBOPLATIN carboplatin INJECTABLE;IV (INFUSION) 077266-001 Feb 15, 2006 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Fresenius Kabi Usa CARBOPLATIN carboplatin INJECTABLE;IV (INFUSION) 077266-003 Feb 15, 2006 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Pharmachemie Bv CARBOPLATIN carboplatin INJECTABLE;IV (INFUSION) 077269-002 Oct 14, 2004 AP RX No Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Pliva CARBOPLATIN carboplatin INJECTABLE;INJECTION 076602-003 Nov 16, 2004 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Hospira CARBOPLATIN carboplatin INJECTABLE;IV (INFUSION) 076517-003 Oct 14, 2004 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Mylan Labs Ltd CARBOPLATIN carboplatin INJECTABLE;IV (INFUSION) 091063-003 Nov 9, 2011 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Ingenus Pharms Llc CARBOPLATIN carboplatin INJECTABLE;IV (INFUSION) 208487-003 Apr 26, 2017 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Pharmachemie Bv CARBOPLATIN carboplatin INJECTABLE;IV (INFUSION) 077679-002 Feb 25, 2009 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
West-ward Pharms Int CARBOPLATIN carboplatin INJECTABLE;INJECTION 076099-002 Oct 14, 2004 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for carboplatin

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Cordenpharma PARAPLATIN carboplatin INJECTABLE;IV (INFUSION) 020452-002 Jul 14, 2003 ➤ Subscribe ➤ Subscribe
Corden Pharma PARAPLATIN carboplatin INJECTABLE;INJECTION 019880-001 Mar 3, 1989 ➤ Subscribe ➤ Subscribe
Corden Pharma PARAPLATIN carboplatin INJECTABLE;INJECTION 019880-002 Mar 3, 1989 ➤ Subscribe ➤ Subscribe
Cordenpharma PARAPLATIN carboplatin INJECTABLE;IV (INFUSION) 020452-003 Jul 14, 2003 ➤ Subscribe ➤ Subscribe
Cordenpharma PARAPLATIN carboplatin INJECTABLE;IV (INFUSION) 020452-001 Jul 14, 2003 ➤ Subscribe ➤ Subscribe
Corden Pharma PARAPLATIN carboplatin INJECTABLE;INJECTION 019880-003 Mar 3, 1989 ➤ Subscribe ➤ Subscribe
Cordenpharma PARAPLATIN carboplatin INJECTABLE;IV (INFUSION) 020452-004 Jan 15, 2004 ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Healthtrust
Boehringer Ingelheim
Baxter
Farmers Insurance
AstraZeneca
Federal Trade Commission
Harvard Business School
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot